• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    DINAMIQS Secures Swissmedic License For Viral Vector Production

    PRESS RELEASE

    Merck & Co.`s Keytruda posts $8B in Q1 as Qlex picks up steam

    FIRSTWORD PHARMA

    Weight-loss drugs may also help cut alcohol intake: Study

    ECONOMICTIMES

    US FDA approves Axsome`s drug for Alzheimer`s-related agitation

    REUTERS

    Novartis Reveals North Carolina Factory In $23B US Expansion

    ENDPOINTS

    Early sales of Lilly’s obesity pill appear to trail Novo’s

    ENDPOINTS

    Fesarius Therapeutics Showcases DermiSphere hDRT Uniqueness

    PR NEWSWIRE

    A.D.A.M. Innovations Empowers NTT Precision Medicine

    GLOBENEWSWIRE

    HHS appeals ruling on Kennedy’s vaccine policies

    RAPS

    Zealand Pharma To Present Q1 2026 Financial Results

    GLOBENEWSWIRE

    YD Bio Limited Reports Full Year 2025 Financial Results

    GLOBENEWSWIRE

    XTL Bio Acquires Psychedelic Biotech; Wuxi Apptec`s Q1 Revenue Up

    ENDPOINTS

    VIVUS Announces QSIVA Price Reduction Across Nordics And Poland

    GLOBENEWSWIRE

    Uniqure Advances AMT-130 For Huntington`s Disease With UK MHRA

    GLOBENEWSWIRE

    Totus Medicines Unveils TOS-358 Data at ESMO Breast Congress

    GLOBENEWSWIRE

    TME Pharma Releases Annual Financial Results And Report

    FIRSTWORD PHARMA

    FDA Approves Theradaptive`s OASIS OsteoAdapt SP for Spinal Fusion

    PR NEWSWIRE

    TLX101-Px (Pixlumi®) MAA Accepted in Europe

    GLOBENEWSWIRE

    Stealth Bio Provides Launch Update & Pipeline Progress

    PR NEWSWIRE

    Solid Biosciences at 29th ASGCT Annual Meeting

    GLOBENEWSWIRE

    Sangamo Therapeutics Showcases Advances At ASGCT Conference

    GLOBENEWSWIRE

    RedHill`s RHB-204 Shows Comparable Efficacy To RHB-104

    PR NEWSWIRE

    Pliant Therapeutics Initiates Phase 1B Trial For PLN-101095

    GLOBENEWSWIRE

    Oncotelic advances AI-enabled robotics platform

    GLOBENEWSWIRE

    NewcelX advances T1D therapy with Eledon Pharmaceuticals

    GLOBENEWSWIRE

    MRM Health drug MH002 gets FDA Fast Track in Ulcerative Colitis

    FIRSTWORD PHARMA

    Single-Cell Multiomics Enables CAR-T Vector Profiling

    FIRSTWORD PHARMA

    Merck Halts TROP ADC Development as Keytruda Clock Ticks

    BIOSPACE

    Medicenna, Fondazione Melanoma Onlus Present NEOCYT Trial

    GLOBENEWSWIRE

    Krystal Biotech To Present At Upcoming Scientific Conferences

    GLOBENEWSWIRE

    KROMATID Unveils Genomic Integrity Benchmarking At ASGCT 2026

    PR NEWSWIRE

    Kriya Showcases Gene Therapy Progress At ASGCT 2026

    GLOBENEWSWIRE

    Immutep Releases Q3 FY26 Activities Report

    GLOBENEWSWIRE

    Immunic To Participate In Investor And Medical Conferences In May

    PR NEWSWIRE

    IDEAYA to file NDA for darovasertib via RTOR Program

    PR NEWSWIRE

    Huahui Health, BeOne Ink Global License for Oncology Drug HH160

    PR NEWSWIRE

    Henlius Doses First Patient in Next-Gen Tetra-Specific Platform

    FIRSTWORD PHARMA

    Hemab Therapeutics Announces Pricing of Upsized IPO

    GLOBENEWSWIRE

    HCW Biologics Postpones Stockholder Meeting For Lack Of Quorum

    FIRSTWORD PHARMA

    Genflow Biosciences PLC Announces Final Results

    PHARMIWEB

    Fibrobiologics Unveils Q1 2026 Financials And Corporate Update

    GLOBENEWSWIRE

    FibroBiologics Announces Poster at SID Meeting 2026

    GLOBENEWSWIRE

    Fate Therapeutics Announces Data Presentation of FT819

    GLOBENEWSWIRE

    Factor Showcases FACT-112 for Ovarian Cancer at ISCT 2026

    PR NEWSWIRE

    Evotec Receives Grants To Advance Tuberculosis Treatment

    PHARMIWEB

    Engeneic Doses First Patient In Recurrent Glioblastoma Trial

    FIRSTWORD PHARMA

    Emergent Biosolutions Gets Singapore Approval To Expand

    GLOBENEWSWIRE

    Elicio Therapeutics Presents at BofA Healthcare Conference

    GLOBENEWSWIRE

    Lilly Initiates Phase 2 Trial For CFTX-1554 In Peripheral Pain

    GLOBENEWSWIRE

    Cue Biopharma Announces $30 Million Private Placement

    FIRSTWORD PHARMA

    Cue Bio Expands Pipeline With Exclusive License

    FIRSTWORD PHARMA

    Corcept Phase 2 Study: Dazucorilant Boosts 2-Year ALS Survival

    FIRSTWORD PHARMA

    Contineum Therapeutics Releases Positive Results From PIPE-791

    FIRSTWORD PHARMA

    Cocrystal Pharma Showcases CDI-988 Progress For Norovirus

    FIRSTWORD PHARMA

    Century Therapeutics Presents CNTY-813 Data at 86th ADA Sessions

    GLOBENEWSWIRE

    Cartesian Therapeutics Unveils Q1 2026 Financials & Business

    GLOBENEWSWIRE

    Can-Fite`s Namodenoson Shows Positive Phase 2A Results

    GLOBENEWSWIRE

    Cadrenal`s Ph3 for CAD-1005 in Heparin-Induced Thrombocytopenia

    GLOBENEWSWIRE

    Krazati fails CRC trial; approval at risk

    ENDPOINTS

    BridgeBio To Present Q1 2026 Financials And Commercial Updates

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.